{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:54:21Z","timestamp":1784688861729,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.biopha.2021.111470","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T21:45:01Z","timestamp":1615671901000},"page":"111470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transition"],"prefix":"10.1016","volume":"138","author":[{"given":"Jian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingnan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biopha.2021.111470_bib1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.biopha.2021.111470_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.biopha.2021.111470_bib4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"Lebleu","year":"2013","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2021.111470_bib5","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3902","article-title":"Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis","volume":"21","author":"Lovisa","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.biopha.2021.111470_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.3901","article-title":"Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease","volume":"21","author":"Grande","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.111470_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1523-1755.2002.00430.x","article-title":"Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies","volume":"62","author":"Rastaldi","year":"2002","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.biopha.2021.111470_bib8","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/ndt\/gft279","article-title":"Expression of the transcriptional regulator snail1 in kidney transplants displaying epithelial-to-mesenchymal transition features","volume":"29","author":"Xu-Dubois","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.biopha.2021.111470_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.2011.04192.x","article-title":"Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy","volume":"76","author":"Zheng","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"18","key":"10.1016\/j.biopha.2021.111470_bib10","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Marc Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.111470_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00018-002-8463-1","article-title":"Enzymes and receptors in the leukotriene cascade","volume":"59","author":"Wetterholm","year":"2002","journal-title":"Cell Mol. Life Sci."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2021.111470_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tox.2011.05.014","article-title":"Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells","volume":"287","author":"Yang","year":"2011","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1378\/chest.130.3.741","article-title":"Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge","volume":"130","author":"Kelly","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.biopha.2021.111470_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1183\/09031936.00143708","article-title":"Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis","volume":"34","author":"Izumo","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"20","key":"10.1016\/j.biopha.2021.111470_bib15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.lfs.2007.02.038","article-title":"Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice","volume":"80","author":"Izumo","year":"2007","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.111470_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/ajrccm.165.2.2104050","article-title":"Protection from pulmonary fibrosis in leukotriene-deficient mice","volume":"165","author":"Marc Peters-Golden","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.biopha.2021.111470_bib17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.41192","article-title":"Promotion of myofibroblast differentiation and tissue fibrosis by the leukotriene B 4 \u2013leukotriene B 4 receptor axis in systemic sclerosis","volume":"72","author":"Minrui","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.biopha.2021.111470_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1096\/fj.02-1157fje","article-title":"Inhibition of 5\u2013lipoxygenase induces cell growth arrest and apoptosis in rat Kupffer cells: implications for liver fibrosis","volume":"17","author":"Titos","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2021.111470_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/3832648","article-title":"The 5-lipoxygenase inhibitor zileuton protects pressure overload-induced cardiac remodeling via activating PPAR\u03b1","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2021.111470_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.66.2.220","article-title":"Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton","volume":"66","author":"Nimesh","year":"2004","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2021.111470_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1472-8206.2011.00996.x","article-title":"Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats","volume":"27","author":"Suddek","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111470_bib22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00210-013-0949-x","article-title":"Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats","volume":"387","author":"Abdel-Raheem","year":"2013","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/0886022X.2011.647305","article-title":"Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats","volume":"34","author":"Beytur","year":"2012","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.biopha.2021.111470_bib24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1152\/ajprenal.00262.2018","article-title":"Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease","volume":"316","author":"John","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2021.111470_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1291\/hypres.29.15","article-title":"Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy","volume":"29","author":"Ikee","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.biopha.2021.111470_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"issue":"32","key":"10.1016\/j.biopha.2021.111470_bib27","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1016\/j.biomaterials.2013.07.014","article-title":"A pH-responsive \u03b1-helical cell penetrating peptide-mediated liposomal delivery system","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ncpneph0098","article-title":"Obstructive nephropathy: towards biomarker discovery and gene therapy","volume":"2","author":"Chevalier","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"8","key":"10.1016\/j.biopha.2021.111470_bib29","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI118612","article-title":"Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis","volume":"97","author":"Jerome Wilborn","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2021.111470_bib30","first-page":"2","article-title":"Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice","volume":"14","author":"Dussaule","year":"2019","journal-title":"Plos One"},{"issue":"2","key":"10.1016\/j.biopha.2021.111470_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1590\/S1677-5538.IBJU.2015.02.14","article-title":"Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats","volume":"41","author":"Otunctemur","year":"2015","journal-title":"Int. Braz. J. Urol."},{"issue":"4","key":"10.1016\/j.biopha.2021.111470_bib32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/gast.2000.18141","article-title":"Leukotrienes induce cell-survival signaling in intestinal epithelial cells","volume":"119","author":"Ohd","year":"2000","journal-title":"Gastroenterology"},{"issue":"46","key":"10.1016\/j.biopha.2021.111470_bib33","doi-asserted-by":"crossref","first-page":"45577","DOI":"10.1074\/jbc.M302881200","article-title":"Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal epithelial cell line Int 407","volume":"278","author":"Paruchuri","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.biopha.2021.111470_bib34","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib35","doi-asserted-by":"crossref","first-page":"L525","DOI":"10.1152\/ajplung.00163.2007","article-title":"TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease","volume":"293","author":"Willis","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111470_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00002018-200730090-00006","article-title":"Clinical pattern of zileuton-associated liver injury results of a 12-month study in patients with chronic asthma","volume":"30","author":"Paul","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.biopha.2021.111470_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1523-1755.2003.00067.x","article-title":"Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction","volume":"64","author":"M Silverstein","year":"2003","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.biopha.2021.111470_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneph.2014.114","article-title":"Inflammatory processes in renal fibrosis","volume":"10","author":"Meng","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.biopha.2021.111470_bib39","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1369\/0022155419852932","article-title":"Renal inflammation and fibrosis: a double-edged sword","volume":"67","author":"Black","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.biopha.2021.111470_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112614","article-title":"Design and synthesis of leukotriene A4 hydrolase inhibitors to alleviate idiopathic pulmonary fibrosis and acute lung injury","volume":"203","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2021.111470_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.111470_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02737605","article-title":"a leukotriene synthesis inhibitor in the management of chronic asthma","volume":"17","author":"Dub\u00e9","year":"1999","journal-title":"Clin. Pharmacokinet. Saf. Clin. Rev. Allergy Immunol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2024.117318","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221002559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:19:26Z","timestamp":1760098766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221002559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"alternative-id":["S0753332221002559"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111470","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.biopha.2024.117318","asserted-by":"object"}]},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transition","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111470"}}